The human D-1A dopamine receptor is transcribed from a tissue-specific regu
lated gene under the control of two promoters. An activator region (AR1) lo
cated between nucleotides -1154 and -1136 (relative to the first ATG) enhan
ces transcription from the upstream promoter that is active in the brain. I
n this investigation, we sought to identify the nuclear factors that regula
te the D-1A gene through their binding to AR1 using yeast one-hybrid screen
ing. Sp3 and Zic2 were among the positive clones isolated. Although Sp1 was
not isolated from this screening and purified Sp1 alone does not bind to A
R1 in gel shift experiments, this general transcription factor binds to AR1
in the presence of D-1A expressing NS20Y nuclear extract and activates the
D-1A promoter. Thus, Sp1 appears to require an unknown factor(s) or post-t
ranslational modification to interact with AR1. On the other hand, Zic2 and
Sp3 inhibit Sp1-induced activation of the D-1A gene in an AR1-dependent ma
nner. Zic2 and D-1A genes have reciprocal brain regional distributions; Zic
2 is expressed primarily in the cerebellum, and D-1A is highly expressed in
corpus striatum. These observations collectively suggest that one of the p
hysiologic functions of Zic2 is repression of D-1A gene transcription and t
hat the intracellular balance among Sp1, Sp3 and Zic2 is important for regu
lating the tissue-specific expression of this dopamine receptor.